title: Use of FDG PET to evaluate hyperbaric oxygen therapy for bisphosphonate-related osteonecrosis of the jaw.
authors.affiliation: Oral Diagnosis and Medicine, Graduate School of Medicine, Hokkaido University, Kita-ku, Sapporo, Japan. yutaka8@den.hokudai.ac.jp
authors.forename: Yutaka
authors.initials: Y
authors.lastname: Yamazaki
authors.forename: Yoshimasa
authors.initials: Y
authors.lastname: Kitagawa
authors.forename: Hironobu
authors.initials: H
authors.lastname: Hata
authors.forename: Takahiro
authors.initials: T
authors.lastname: Abe
authors.forename: Chika
authors.initials: C
authors.lastname: Murai
authors.forename: Tohru
authors.initials: T
authors.lastname: Shiga
authors.forename: Nagara
authors.initials: N
authors.lastname: Tamaki
mesh_terms: D000369:Aged, 80 and over; D004164:Diphosphonates / Q000494:pharmacology*; D019788:Fluorodeoxyglucose F18; D006801:Humans; D006931:Hyperbaric Oxygenation; D007568:Jaw / Q000000981:diagnostic imaging*; D008297:Male; D010020:Osteonecrosis / Q000139:chemically induced / Q000000981:diagnostic imaging* / Q000628:therapy*; D049268:Positron-Emission Tomography; D016896:Treatment Outcome
chemical_list: D004164:Diphosphonates; D019788:Fluorodeoxyglucose F18